MeiraGTx Holdings (MGTX) Capital Leases (2017 - 2025)
MeiraGTx Holdings (MGTX) posted Capital Leases of $109000.0 for Q4 2025, down 99.36% on a QoQ basis from $17.1 million in Q3 2020.
MeiraGTx Holdings (MGTX) Capital Leases (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' Capital Leases history runs 5 years deep, the most recent figure standing at $109000.0 for Q4 2025.
- Quarterly Capital Leases changed N/A year-over-year to $109000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $109000.0 (changed N/A YoY) and the FY2025 annual result came in at $109000.0, changed N/A from the prior year.
- Capital Leases was $109000.0 for Q4 2025 at MeiraGTx Holdings, down from $17.1 million in the prior quarter.
- Across five years, Capital Leases topped out at $109000.0 in Q4 2025 and bottomed at $109000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 109,000.00 |
| Sep 30, 2020 | 17.13 Mn |
| Jun 30, 2020 | 18.56 Mn |
| Mar 31, 2020 | 19.17 Mn |
| Dec 31, 2019 | 21.50 Mn |
| Sep 30, 2019 | 20.60 Mn |
| Jun 30, 2019 | 15.39 Mn |
| Mar 31, 2019 | 2.91 Mn |
| Dec 31, 2018 | 7,097.00 |
| Sep 30, 2018 | 12,092.00 |
| Jun 30, 2018 | 20,732.00 |
| Dec 31, 2017 | 34,298.00 |